KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) Operating Expenses (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Operating Expenses for 16 consecutive years, with -$16.7 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 66.83% to -$16.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.7 million through Dec 2025, up 44.25% year-over-year, with the annual reading at $78.7 million for FY2025, 44.25% up from the prior year.
  • Operating Expenses for Q4 2025 was -$16.7 million at Biolife Solutions, down from $28.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $117.1 million in Q2 2022, with the low at -$131.6 million in Q4 2022.
  • Average Operating Expenses over 5 years is $22.1 million, with a median of $32.0 million recorded in 2021.
  • The sharpest move saw Operating Expenses surged 262.08% in 2021, then tumbled 335.98% in 2022.
  • Over 5 years, Operating Expenses stood at $55.8 million in 2021, then tumbled by 335.98% to -$131.6 million in 2022, then surged by 55.77% to -$58.2 million in 2023, then surged by 82.84% to -$10.0 million in 2024, then plummeted by 66.83% to -$16.7 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at -$16.7 million, $28.2 million, and $42.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.